Rischin D, Migden MR, Chang ALS, al. E. Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma. J of Skin [Internet]. 2018 Dec. 17 [cited 2024 Jul. 3];2:S79. Available from: https://jofskin.org/33014/index.php/skin/article/view/475